What is the outcome of targeted tuberculosis screening based on universal genotyping and location?

Patrick K. Moonan, Joseph Oppong, Behzad Sahbazian, Karan P. Singh, Raghbir Sandhu, Gerry Drewyer, Terry LaFon, Marco Marruffo, Teresa N. Quitugua, Charles Wallace, Stephen Weis

Research output: Contribution to journalArticleResearchpeer-review

31 Citations (Scopus)

Abstract

Rationale and Objectives: Identifying and treating persons with latent tuberculosis (TB) infection (LTBI) at high risk for developing TB is part of the current TB elimination strategy. There are no specific criteria, other than medical risks, to designate groups as high risk for developing TB. We hypothesized that, if location-based screenings were done in communities where persons with genotypically clustered Mycobacterium tuberculosis resided, then persons with LTBI from recent transmission and with undiagnosed TB could be identified. Methods: Location-based TB screenings were done in partnership with multiple community-based organizations using resources previously used for other types of screening. Main Results: Location-based screenings identified one person with TB for every 83 screened, and one person with LTBI for every five screened. The yield of this targeted screening program for discovering persons with TB and LTBI exceeded what would be expected from nontargeted screening in a county with a TB incidence of 5.7 per 100,000 population. Conclusions: Genotyping combined with geographic information systems analysis can potentially be used to define high-risk status and to define areas for location-based TB screenings.

Original languageEnglish
Pages (from-to)599-604
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume174
Issue number5
DOIs
StatePublished - 1 Sep 2006

Fingerprint

Tuberculosis
Latent Tuberculosis
Geographic Information Systems
Systems Analysis
Mycobacterium tuberculosis
Incidence
Population

Keywords

  • Genotyping
  • Location-based screening
  • Mycobacterium tuberculosis

Cite this

Moonan, Patrick K. ; Oppong, Joseph ; Sahbazian, Behzad ; Singh, Karan P. ; Sandhu, Raghbir ; Drewyer, Gerry ; LaFon, Terry ; Marruffo, Marco ; Quitugua, Teresa N. ; Wallace, Charles ; Weis, Stephen. / What is the outcome of targeted tuberculosis screening based on universal genotyping and location?. In: American Journal of Respiratory and Critical Care Medicine. 2006 ; Vol. 174, No. 5. pp. 599-604.
@article{b781c2cea7bf48658199273563912405,
title = "What is the outcome of targeted tuberculosis screening based on universal genotyping and location?",
abstract = "Rationale and Objectives: Identifying and treating persons with latent tuberculosis (TB) infection (LTBI) at high risk for developing TB is part of the current TB elimination strategy. There are no specific criteria, other than medical risks, to designate groups as high risk for developing TB. We hypothesized that, if location-based screenings were done in communities where persons with genotypically clustered Mycobacterium tuberculosis resided, then persons with LTBI from recent transmission and with undiagnosed TB could be identified. Methods: Location-based TB screenings were done in partnership with multiple community-based organizations using resources previously used for other types of screening. Main Results: Location-based screenings identified one person with TB for every 83 screened, and one person with LTBI for every five screened. The yield of this targeted screening program for discovering persons with TB and LTBI exceeded what would be expected from nontargeted screening in a county with a TB incidence of 5.7 per 100,000 population. Conclusions: Genotyping combined with geographic information systems analysis can potentially be used to define high-risk status and to define areas for location-based TB screenings.",
keywords = "Genotyping, Location-based screening, Mycobacterium tuberculosis",
author = "Moonan, {Patrick K.} and Joseph Oppong and Behzad Sahbazian and Singh, {Karan P.} and Raghbir Sandhu and Gerry Drewyer and Terry LaFon and Marco Marruffo and Quitugua, {Teresa N.} and Charles Wallace and Stephen Weis",
year = "2006",
month = "9",
day = "1",
doi = "10.1164/rccm.200512-1977OC",
language = "English",
volume = "174",
pages = "599--604",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "5",

}

Moonan, PK, Oppong, J, Sahbazian, B, Singh, KP, Sandhu, R, Drewyer, G, LaFon, T, Marruffo, M, Quitugua, TN, Wallace, C & Weis, S 2006, 'What is the outcome of targeted tuberculosis screening based on universal genotyping and location?', American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 5, pp. 599-604. https://doi.org/10.1164/rccm.200512-1977OC

What is the outcome of targeted tuberculosis screening based on universal genotyping and location? / Moonan, Patrick K.; Oppong, Joseph; Sahbazian, Behzad; Singh, Karan P.; Sandhu, Raghbir; Drewyer, Gerry; LaFon, Terry; Marruffo, Marco; Quitugua, Teresa N.; Wallace, Charles; Weis, Stephen.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 174, No. 5, 01.09.2006, p. 599-604.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - What is the outcome of targeted tuberculosis screening based on universal genotyping and location?

AU - Moonan, Patrick K.

AU - Oppong, Joseph

AU - Sahbazian, Behzad

AU - Singh, Karan P.

AU - Sandhu, Raghbir

AU - Drewyer, Gerry

AU - LaFon, Terry

AU - Marruffo, Marco

AU - Quitugua, Teresa N.

AU - Wallace, Charles

AU - Weis, Stephen

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Rationale and Objectives: Identifying and treating persons with latent tuberculosis (TB) infection (LTBI) at high risk for developing TB is part of the current TB elimination strategy. There are no specific criteria, other than medical risks, to designate groups as high risk for developing TB. We hypothesized that, if location-based screenings were done in communities where persons with genotypically clustered Mycobacterium tuberculosis resided, then persons with LTBI from recent transmission and with undiagnosed TB could be identified. Methods: Location-based TB screenings were done in partnership with multiple community-based organizations using resources previously used for other types of screening. Main Results: Location-based screenings identified one person with TB for every 83 screened, and one person with LTBI for every five screened. The yield of this targeted screening program for discovering persons with TB and LTBI exceeded what would be expected from nontargeted screening in a county with a TB incidence of 5.7 per 100,000 population. Conclusions: Genotyping combined with geographic information systems analysis can potentially be used to define high-risk status and to define areas for location-based TB screenings.

AB - Rationale and Objectives: Identifying and treating persons with latent tuberculosis (TB) infection (LTBI) at high risk for developing TB is part of the current TB elimination strategy. There are no specific criteria, other than medical risks, to designate groups as high risk for developing TB. We hypothesized that, if location-based screenings were done in communities where persons with genotypically clustered Mycobacterium tuberculosis resided, then persons with LTBI from recent transmission and with undiagnosed TB could be identified. Methods: Location-based TB screenings were done in partnership with multiple community-based organizations using resources previously used for other types of screening. Main Results: Location-based screenings identified one person with TB for every 83 screened, and one person with LTBI for every five screened. The yield of this targeted screening program for discovering persons with TB and LTBI exceeded what would be expected from nontargeted screening in a county with a TB incidence of 5.7 per 100,000 population. Conclusions: Genotyping combined with geographic information systems analysis can potentially be used to define high-risk status and to define areas for location-based TB screenings.

KW - Genotyping

KW - Location-based screening

KW - Mycobacterium tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=33748310583&partnerID=8YFLogxK

U2 - 10.1164/rccm.200512-1977OC

DO - 10.1164/rccm.200512-1977OC

M3 - Article

VL - 174

SP - 599

EP - 604

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 5

ER -